For example, loss of ZFHX3 dramatically increased MYC expression in both C4-2B and LNCaP prostate cancer cells (Fig. 3), and ZFHX3 clearly bound to the MYC promoter (Fig. 5). This evidence concerns the gene MYC and prostate carcinoma.